Cs Pharmaon Business Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.00 M
- Revenue Growth %
- Profit Growth 96.03%
- Ebitda 97.52%
- Net Worth -0.38%
- Total Assets -0.53%
About Cs Pharmaon Business
Cs Pharmaon Business Private Limited (CPBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 September 2011 and has a history of 13 years and five months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Cs Boschem Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Sureshkumar Pandey and Ranjana Pandey serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51101MH2011PTC221473
-
Company No.
221473
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Sep 2011
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cs Pharmaon Business?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sureshkumar Pandey
|
Director | 02-Sep-2011 | Current |
|
Ranjana Pandey
|
Director | 02-Sep-2011 | Current |
Financial Performance of Cs Pharmaon Business.
Cs Pharmaon Business Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 96.03% increase in profit. The company's net worth dipped by a decrease of 0.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cs Pharmaon Business?
In 2017, Cs Pharmaon Business had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dnaztra Ip Technofab Private LimitedSureshkumar Pandey and Ranjana Pandey are mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Navi Mumbai Co-Op. Bank Ltd. : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2011 | Navi Mumbai Co-Op. Bank Ltd. | ₹1.00 M | Open |
How Many Employees Work at Cs Pharmaon Business?
Unlock and access historical data on people associated with Cs Pharmaon Business, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cs Pharmaon Business, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cs Pharmaon Business's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.